Omnicell has completed the acquisition of UK-based SurgiChem, a wholly-owned subsidiary of Bupa Care Homes (CFG), following approval from the Competition and Markets Authority (CMA) in the UK. CFG will now be integrated with Omnicell's ...
Tags: Omnicell, Acquisition, Packaging
Only 1 in 10 people who need palliative care - that is medical care to relieve the pain, symptoms and stress of serious illness - is currently receiving it. This unmet need is mapped for the first time in the "Global atlas of palliative ...
Tags: WPCA, HIV, drug-resistant tuberculosis, health-care systems
Boston Scientific has received CE Mark approval for the Rhythmia Mapping System, a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures to treat abnormal heart ...
Tags: CE Mark, 3D Mapping System
Biopharmaceutical company Pfizer has decided to discontinue the development of filibuvir, an experimental hepatitis C drug, following a strategic review and capital allocation. The drug, which is in mid-stage clinical testing, is facing ...
Tags: Pfizer, filibuvir drug, drug
xG Technology, a developer of a portfolio of wireless communications technologies, has entered into a reseller agreement with New York-based health care systems integrator Telemedicine-MM Systems. Under the term of the agreement till 31 ...
The software solution is designed for all types of patient interactions within hospitals including after an inpatient discharge, emergency department visit, radiology test, same-day surgery, or specialty procedure. LA GRANGE, IL, February ...
Tags: Smart-ER, Patient Contact System, software
Mylan has unveiled Atorvastatin calcium tablets of strengths 10mg, 20mg, 40mg and 80mg in Belgium, France, the UK, Ireland and the Netherlands. The generic version of Pfizer's Lipitor is indicated to prevent cardiovascular disease and ...
Tags: Mylan, Atorvastatin calcium tablets, cardiovascular disease
Uluru said that the first shipment of Altrazeal has been received by its marketing partner in Australia. Altrazeal, a wound treatment technology, has shown clinical and economic advantages in a number of chronic and acute wounds, which ...
Tags: Altrazeal, wound treatment technology, marketing partner